Kestra Medical Technologies (KMTS) EBT (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported EBT for 3 consecutive years, with -$38.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT rose 24.24% year-over-year to -$38.6 million in Q2 2026; TTM through Apr 2026 was -$131.3 million, a 15.52% decrease from a year earlier, with the FY2026 full-year figure at -$131.3 million, down 15.52% from the prior year.
• EBT was -$38.6 million for Q2 2026 at Kestra Medical Technologies, down from -$34.1 million in the prior quarter.
• Over five years, EBT peaked at -$20.3 million in Q3 2024 and troughed at -$51.0 million in Q2 2025.
• A 3-year average of -$28.9 million and a median of -$24.1 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT plunged 128.63% in 2025 and grew 24.24% in 2026, its largest moves.
• Over 3 years, EBT stood at -$20.6 million in 2024, then sank by 58.89% to -$32.8 million in 2025, then retreated by 17.99% to -$38.6 million in 2026.
• The last three EBT figures came in at -$38.6 million (Q2 2026), -$34.1 million (Q1 2026), and -$32.8 million (Q4 2025), per Business Quant data.